Although VL30 retrotransposable elements have been associated with cer
tain cancers for nearly twenty years, because of their expression in r
odent malignancies and recombination into murine sarcoma viruses, thei
r causative role, if any, in cancer has been uncertain and enigmatic.
Recent findings suggest loss of normal transcriptional control of spec
ific VL30 element expression may make a critical contribution to tumor
progression at a step associated with malignant conversion, by bringi
ng into play a cellular program normally involved in wound healing. Th
is program, the fibroblast anoxic response system, includes an adaptat
ion to glycolytic metabolism, secretion of metalloproteinases, and act
ivation of an endonuclease. While appropriate for facilitating debris
removal during wound healing, loss of control of this program in a cel
l which has already progressed to the benign neoplastic state has the
potential to simultaneously produce the invasiveness and genomic insta
bility characteristic of malignancy. Examination of tumors and tumor d
erived cell lines has confirmed that key aspects of this system are in
fact activated in cancer.